Oncotarget

Search Oncotarget

Clear all
738 results found — showing 41–60

Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion Research Paper

Stefan Steurer, Lara Schwemmer, Claudia Hube-Magg, Franziska Büscheck, Doris Höflmayer, Maria Christina Tsourlakis, Till S. Clauditz, Andreas M. Luebke, Ronald Simon, Guido Sauter, Jakob Izbicki, Cornelia Schroeder, Thorsten Schlomm, Hartwig Huland, Hans Heinzer, Alexander Haese, Markus Graefen, Cosima Göbel, Sören Weidemann, Patrick Lebok, David Dum, Christoph Fraune, Sarah Minner, Jan Meiners
Published Dec 24, 2019 · Vol. 10, No. 67 · pp. 7096-7111
Keywords: BAP1, prostate cancer, prognosis, immunohistochemistry

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study Research Paper

Sarina A. Piha-Paul, Matthew H. Taylor, Daniel Spitz, Lee Schwartzberg, J. Thaddeus Beck, Todd M. Bauer, Funda Meric-Bernstam, Das Purkayastha, Linda Karpiak, Sebastian Szpakowski, Fadi Braiteh
Published Nov 5, 2019 · Vol. 10, No. 60 · pp. 6526-6535
Keywords: phosphatidylinositol 3-kinase pathway, buparlisib, advanced malignancies, molecular selection, tissue agnostic

Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS) Research Paper

Goro Kasuya, Kazuki Terashima, Kei Shibuya, Shingo Toyama, Daniel K. Ebner, Hiroshi Tsuji, Tomoaki Okimoto, Tatsuya Ohno, Yoshiyuki Shioyama, Takashi Nakano, Tadashi Kamada, the Japan Carbon-Ion Radiation Oncology Study Group
Published Jul 9, 2019 · Vol. 10, No. 43 · pp. 4369-4379
Keywords: carbon-ion radiotherapy, radiation, cholangiocarcinoma, adverse event, survival

Multidisciplinary palliation for unresectable recurrent rectal cancer: hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study Research Paper

Stefano Guadagni, Giammaria Fiorentini, Andrea Mambrini, Francesco Masedu, Marco Valenti, Andrew Reay Mackay, Donatella Sarti, Enrico Ricevuto, Marco Clementi, Marco Catarci, Gianni Lazzarin, Gemma Bruera
Published Jun 11, 2019 · Vol. 10, No. 39 · pp. 3840-3851
Keywords: hypoxic pelvic perfusion with mitomycin C and oxaliplatin, unresectable recurrent rectal cancer, retrospective cohort study

PRMT5 prognostic value in cancer Research Perspective

Hanine Lattouf, Coralie Poulard, Muriel Le Romancer
Published May 13, 2019
Keywords: arginine methylation, PRMT5, breast cancer, biomarker

PRMT5 prognostic value in cancer Research Perspective

Hanine Lattouf, Coralie Poulard, Muriel Le Romancer
Published May 7, 2019 · Vol. 10, No. 34 · pp. 3151-3153

Defining molecular risk in ALK+ NSCLC Research Perspective

Petros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger Sültmann, Michael Thomas, Albrecht Stenzinger
Published May 3, 2019 · Vol. 10, No. 33 · pp. 3093-3103

PD-L1 checkpoint blockade delivered by retroviral replicating vector confers anti-tumor efficacy in murine tumor models Research Paper

Leah A. Mitchell, Kader Yagiz, Andrew Hofacre, Sophie Viaud, Anthony W. Munday, Fernando Lopez Espinoza, Daniel Mendoza, Maria E. Rodriguez-Aguirre, Simon Bergqvist, Ali Haghighi, Marin V. Miner, William P. Accomando, Cynthia Burrascano, Dawn Gammon, Harry E. Gruber, Douglas J. Jolly, Amy H. Lin
Published Mar 19, 2019 · Vol. 10, No. 23 · pp. 2252-2269
Keywords: immunotherapy, single chain variable fragment, retroviral replicating vector, PD-L1, PD-1

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer Research Paper

Till Eichenauer, Mohammad Hussein, Claudia Hube-Magg, Martina Kluth, Franziska Büscheck, Doris Höflmayer, Maria Christina Tsourlakis, Stefan Steurer, Till S. Clauditz, Andreas M. Luebke, Eike Burandt, Waldemar Wilczak, Andrea Hinsch, David Dum, Burkhard Beyer, Thomas Steuber, Hartwig Huland, Markus Graefen, Ronald Simon, Guido Sauter, Nathaniel Melling, Thorsten Schlomm, Sarah Minner
Published Mar 1, 2019 · Vol. 10, No. 18 · pp. 1729-1744

Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma Research Paper

Goro Kasuya, Hiroshi Tsuji, Takuma Nomiya, Hirokazu Makishima, Yasuo Haruyama, Gen Kobashi, Kazuhiko Hayashi, Daniel K. Ebner, Tokuhiko Omatsu, Riwa Kishimoto, Shigeo Yasuda, Tatsuo Igarashi, Mototsugu Oya, Koichiro Akakura, Hiroyoshi Suzuki, Tomohiko Ichikawa, Jun Shimazaki, Tadashi Kamada and the Working Group for Genitourinary Tumors
Published Jan 1, 2019 · Vol. 10, No. 1 · pp. 76-81
By using our site you are giving us permission to use cookies. This website collects cookies to deliver a better user experience, and to analyze our website traffic and performance. Personal data is not collected.